MediPharm Labs Press Releases

MediPharm Labs Announces Q1 2019 Revenue of $22 Million and Adjusted EBITDA of $4.3 Million

May 10, 2019

MediPharm Labs Sets Date to Release First Quarter 2019 Financial Results

May 8, 2019

MediPharm Labs Announces Upgrade to the OTCQX Best Market in the U.S. Under Symbol “MEDIF”

May 2, 2019

MediPharm Labs Appoints Renowned Medical Expert and Pharmaceutical Researcher Dr. Paul Tam to its Board of Directors

May 1, 2019

MediPharm Labs Appoints Former Johnson & Johnson Group Product Director as Chief Strategy Officer

Apr 29, 2019

MediPharm Labs Announces DTC Eligibility, Increasing Accessibility for US Investors

Apr 16, 2019

MediPharm Labs Announces OTC Ticker Symbol Change to “MEDIF”

Apr 9, 2019

MediPharm Labs Assembles Globally Renowned Experts to Form Scientific Advisory Committee

Apr 8, 2019

MediPharm Labs Reports Q4 2018 Revenue of $10.2 Million and Adjusted EBITDA of $2.1 Million

Apr 3, 2019

MediPharm Labs Acquires Over 5,000 KG of Dried Cannabis for Private Label Cannabis Oil Production and Launches New White Label Solutions Platform

Apr 1, 2019